J Mol Recognit. 2026 Jul;39(4):e70042. doi: 10.1002/jmr.70042.
ABSTRACT
Atomic Force Microscopy (AFM) based single molecule recognition has emerged as a transformative paradigm in nanoscale biology, enabling direct investigation of biological interactions under physiological conditions. This technology bridges critical gaps between structural characterization and functional analysis by providing unparalleled capabilities for quantifying binding forces, mapping molecular distributions, and resolving kinetic parameters at the single molecule level. The core methodology relies on precision probe functionalization strategies, such as oriented immobilization and polyethylene glycol (PEG) linkers, to ensure specific recognition while minimizing nonspecific interactions. Advanced techniques, including single molecule force spectroscopy (SMFS) and topography and recognition imaging (TREC), allow simultaneous acquisition of morphological and binding data with nanometer resolution, revealing insights into molecular organization and dynamics. Applications span diverse domains, from fundamental studies of antigen-antibody interactions and DNA-protein binding to clinical investigations of membrane receptor distributions in cancer cells and pathological diagnosis based on mechanical properties. Despite challenges in throughput, signal resolution, and standardization, integration with super-resolution microscopy and spectroscopic techniques demonstrates significant potential. Future developments emphasize multimodal correlation, artificial intelligence-assisted data analysis, and clinical translation toward nano biopsy, positioning AFM as a highly valuable and complementary platform for advancing molecular biophysics, drug discovery, and personalized medicine, notably due to its unique capability to combine nanoscale imaging with single-molecule force measurement on the same sample under physiological conditions.
PMID:42425917 | DOI:10.1002/jmr.70042